MASTERBEEF GROUP Announces Closing of Partial Exercise of Over-Allotment Option in its Initial Public Offering
Hong Kong, May 16, 2025 (GLOBE NEWSWIRE) -- MasterBeef Group (the 'Company'), a full-service restaurant group in Hong Kong, specializing in Taiwanese hotpot and Taiwanese barbecue, today announced today that it has issued an additional 155,000 ordinary shares (the "Ordinary Shares") at a price of US$4.00 per share for gross proceeds of approximately $620,000, before deducting underwriter discounts and other related expenses, pursuant to the partial exercise of the underwriter's over-allotment option in connection with the Company's previously announced initial public offering (the 'Offering'). The option closing date was May 16, 2025. The ordinary shares began trading on the Nasdaq Capital Market on April 10, 2025 under the ticker symbol 'MB.'
The Company expects to use the net proceeds from the Offering and the exercise of the over-allotment option for (i) the expansion of its restaurant network through the establishment of new restaurant outlets and its franchising endeavors in Hong Kong and overseas including Singapore and other Southeast Asian countries; (ii) its marketing and branding campaigns, including marketing and promotional activities to further expand its customer base and strengthen its brands; (iii) the production and sale of semi-finished food products such as packaged hotpot soup base and marinated food products; (iv) the investment in technology solutions for table service, inventory management and order processing, and the upgrade of the IT systems in its restaurant outlets; and (v) general corporate purposes that are beneficial in developing the business and its strategic direction.
Dominari Securities LLC acted as the lead underwriter for the Offering and Revere Securities LLC acted as a co-underwriter. Schlueter & Associates, P.C. acted as U.S. securities counsel to the Company, and Hunter Taubman Fischer & Li LLC acted as U.S. securities counsel to the underwriters in connection with the Offering.
A registration statement on Form F-1 relating to the Offering was filed with the U.S. Securities and Exchange Commission (the 'SEC') (File Number: 333-283142) and was declared effective by the SEC on March 31, 2025. The Offering is being made only by means of a prospectus, forming a part of the registration statement. Copies of the prospectus relating to the Offering may be obtained, when available, from Dominari Securities LLC, 725 Fifth Avenue, 23rd Floor, New York, NY 10022, or by email at investmentbanking@dominarisecurities.com, or by telephone at (212) 393-4500, or Revere Securities LLC, 560 Lexington Avenue, 16th Floor, New York, NY 10022, or by email at contact@reveresecurities.com, or by telephone at (212) 688-2350. In addition, copies of the prospectus relating to the Offering may be obtained via the SEC's website at www.sec.gov.
This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, any of the Company's securities, nor shall such securities be offered or sold in the United States absent registration or an applicable exemption from registration, nor shall there be any offer, solicitation or sale of any of the Company's securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About MasterBeef Group
MasterBeef Group is a full-service restaurant group in Hong Kong, specializing in Taiwanese hotpot and Taiwanese barbecue. The Company, through its Hong Kong Operating Subsidiaries, operates 12 restaurant outlets under the Master Beef and Anping Grill brands. For more information, please visit the Company's website: masterbeefgroup.com.
Forward-Looking Statements
Certain statements in this press release are forward-looking statements These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as 'approximates,' 'believes,' 'hopes,' 'expects,' 'anticipates,' 'estimates,' 'projects,' 'intends,' 'plans,' 'will,' 'would,' 'should,' 'could,' 'may' or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. These statements are subject to uncertainties and risks, including, but not limited to, the uncertainties related to market conditions, and other factors discussed in the 'Risk Factors' section of the Registration Statement filed with the SEC. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and other filings with the SEC. Additional factors are discussed in the Company's filings with the SEC, which are available for review at www.sec.gov.
For more information, please contact:
MasterBeef GroupEmail: ir@masterbeefgroup.comSign in to access your portfolio

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
CNOOC Limited Subsidiary Signed EPC on the Zhylyoi Subsoil Area
HONG KONG, June 24, 2025 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces its wholly owned subsidiary, CNOOC Hong Kong Holding Limited, has entered into the Contract for Exploration and Production of Hydrocarbons (EPC) on the Zhylyoi Subsoil Area with Ministry of Energy of the Republic of Kazakhstan and Joint Stock Company National Company KazMunayGas (KMG). The Zhylyoi Subsoil Area is located partially in the Atyrau region and partially in the Kazakhstan sector of the Caspian Sea, with an area of approximately 958 square kilometers. According to the terms of the contract, the first stage of the exploration period shall be 9 years. CNOOC Hong Kong Holding Limited and KMG shall each hold 50% interests. The two parties shall establish a joint operating company and act as the operator. — End — Notes to Editors: More information about the Company is available at *** *** *** *** This press release includes forward looking information, including statements regarding the likely future developments in the business of the Company and its subsidiaries, such as expected future events, business prospects or financial results. The words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify such forward-looking statements. These statements are based on assumptions and analyses made by the Company as of this date in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors that the Company currently believes are appropriate under the circumstances. However, whether actual results and developments will meet the current expectations and predictions of the Company is uncertain. Actual results, performance and financial condition may differ materially from the Company's expectations, including but not limited to those associated with macro-political and economic factors, fluctuations in crude oil and natural gas prices, the highly competitive nature of the oil and natural gas industry, climate change and environmental policies, the Company's price forecast, mergers, acquisitions and divestments activities, HSSE and insurance policies and changes in anti-corruption, anti-fraud, anti-money laundering and corporate governance laws and regulations. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements. The Company cannot assure that the results or developments anticipated will be realised or, even if substantially realised, that they will have the expected effect on the Company, its business or operations. *** *** *** *** For further enquiries, please contact: Ms. Cui LiuMedia & Public RelationsCNOOC LimitedTel: +86-10-8452-6641Fax: +86-10-8452-1441E-mail: mr@ Mr. Cheng YaoEver Bloom (HK) Communications Consultants Group LimitedTel: +852 5540 0725Fax: +852 2111 1103Email: View original content to download multimedia: SOURCE CNOOC Limited Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
36 minutes ago
- Yahoo
Eli Lilly (LLY) Retains $1,100 Price Target at Bernstein Ahead of Diabetes Conference
Eli Lilly & Company (NYSE:LLY) is one of billionaire Stan Druckenmiller's top stock picks with huge upside potential. Bernstein SocGen Group reaffirmed its Outperform rating and $1,100 price target for Eli Lilly & Company (NYSE:LLY) on June 13 ahead of the 85th Annual Meeting of the American Diabetes Association. Pixabay/Public Domain The firm outlined a number of crucial data presentations that Eli Lilly & Company (NYSE:LLY) is expected to provide at the next meeting. One of these is the full description of the ACHIEVE-1 study, which is the first phase 3 trial from the late-stage clinical program of orforglipron. Bernstein is especially keen to acquire more information on the negative event profile and discontinuation rates, even if topline data is already available. Additionally, Eli Lilly & Company (NYSE:LLY) will provide information about its muscle-wasting medication, bimagrumab. When paired with tirzepatide, this will be the first clinical data reported for an anti-muscle wasting agent used in conjunction with a GLP-1 receptor agonist, possibly hinting at future use cases. Eli Lilly & Company (NYSE:LLY) is a major global pharmaceutical company that develops, manufactures, and distributes a wide range of drugs. Founded in 1876, it has grown to become one of the world's largest pharmaceutical companies. While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Connectez-vous pour accéder à votre portefeuille


Bloomberg
3 hours ago
- Bloomberg
Chinese Port Activity Surges to Record After Trade Truce With US
Chinese ports just had their busiest week on record, likely due to exporters racing to get goods into the US as quickly as possible ahead of tariffs that may be imposed early next month. Some 6.7 million standard containers were shipped domestically and internationally last week, the Ministry of Transport said on Tuesday. The almost 6% jump in traffic from the previous week came after a trade truce agreed with Washington earlier in June. In May, Chinese exports to the US fell the most since the early days of the pandemic.